HAYASHI Motohiro
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine
   Position   Professor
Article types Other
Language Japanese
Peer review Peer reviewed
Title [Study on medical economic evaluation methods for metastatic brain tumors therapy]
Journal Formal name:Neurological Surgery
ISSN code:03012603
Domestic / ForeginDomestic
Volume, Issue, Page pp.629-637
Publication date 2010/07
Summary Treatment design for metastatic brain tumors is required to firstly care about the life and function for which the patient hopes because it is terminal care. Therefore, to discuss the value of the therapy, a viewpoint of the QOL and the socioeconomic factors other than the survival rate is important. However, examination that applies these factors to the therapy needs to be carried out more thoroughly. With this in mind, we discuss cost effectiveness of therapy for metastatic brain tumor, through a pilot study on gamma knife therapy.|We studied 18 patients (mean age 61.6 years old) undergoing therapy for metastatic brain tumors. The health rate QOL was assessed by the profile-type measure SF-36 (Short-Form 36-Item Ver1.2) and the preference-based measure EQ-5D (EuroQoL-5D), before and six months after gamma knife therapy. Cost-utility-analysis (yen/Qaly) was carried out from quality adjusted life years (Qalys) and medical fee claims. In addition, we made a correlation analysis of the irradiation procedure and the gains attained.|The observation by SF-36 for six months was useful for metastatic brain tumor.
DOI doi.org/10.11477/mf.1436101210
Document No. 20628189